Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer
Dr Kimberly H Allison from Stanford Cancer Institute in Stanford, California, discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.